Boehringer Ingelheim is dedicated to the research and development of medical products to improve, sustain and care for life.
We have a reputation for providing effective products for the treatment of chronic obstructive pulmonary disease (COPD), heart attack, secondary stroke prevention and treatment, high blood pressure, thromboembolic disease, HIV/AIDS, Parkinson’s disease, stroke, diabetes and Non Small Cell Lung Cancer (NSCLC).
Our products are supported by a wide range of services, designed to help the medical profession deliver the best possible healthcare to patients.
This underlines our commitment to improving health and quality of life in the UK.
Boehringer Ingelheim is a family owned company whose distinctly independent structure means that we are not constrained by the short-term needs of individual shareholders and can focus on the future with long-term strategies of vision and leadership.
Despite our aim to change and adapt for the future, we will never change the belief that our employees are our most valuable asset.
We are proud to have been ranked among the top 100 Best Companies regularly over the last 10 years..
The spirit and teamwork of our global family will remain the key to our continuing success.
For more information, please go to our website here and watch our video “What Drives Us”